Independent CE Satellite Symposium: From Sledgehammer to Selective: Transforming Cytotoxic Potency Through Targeted Treatments for Advanced or Metastatic Urothelial Cancer
Tuesday, October 27, 2020
4:00 PM – 5:15 PM EDT
Elizabeth R. Plimack, MD, MS Chief, Division of Genitourinary Medical Oncology Professor, Department of Hematology/Oncology Director, Genitourinary Clinical Research Fox Chase Cancer Center Temple University Health System Philadelphia, Pennsylvania
Susan K. Roethke, CRNP, MSN, ANP-BC, AOCNP Certified Registered Nurse Practitioner Genitourinary Medical Oncology Dept of Hematology/Oncology Fox Chase Cancer Center Temple University Health System Philadelphia, Pennsylvania
Brought to you by Integrity Continuing Education, an independent medical education company.
This activity supported by educational grants from Astellas, Merck Sharp & Dohme, and Seattle Genetics.